JCR Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
JCR Pharmaceuticals has a total shareholder equity of ¥55.7B and total debt of ¥28.2B, which brings its debt-to-equity ratio to 50.7%. Its total assets and total liabilities are ¥104.2B and ¥48.5B respectively. JCR Pharmaceuticals's EBIT is ¥5.0B making its interest coverage ratio -66.1. It has cash and short-term investments of ¥18.3B.
Key information
50.7%
Debt to equity ratio
JP¥28.22b
Debt
| Interest coverage ratio | -66.1x |
| Cash | JP¥18.34b |
| Equity | JP¥55.67b |
| Total liabilities | JP¥48.50b |
| Total assets | JP¥104.17b |
Recent financial health updates
No updates
Recent updates
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00
Sep 06
What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You
Sep 04JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00
Aug 23JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00
Aug 09Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts
Aug 03JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00
Jul 26JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00
Jul 12JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
May 22JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00
Mar 18JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00
Feb 29Financial Position Analysis
Short Term Liabilities: 4552's short term assets (¥57.8B) exceed its short term liabilities (¥32.9B).
Long Term Liabilities: 4552's short term assets (¥57.8B) exceed its long term liabilities (¥15.6B).
Debt to Equity History and Analysis
Debt Level: 4552's net debt to equity ratio (17.8%) is considered satisfactory.
Reducing Debt: 4552's debt to equity ratio has increased from 17.9% to 50.7% over the past 5 years.
Debt Coverage: 4552's debt is well covered by operating cash flow (33%).
Interest Coverage: 4552 earns more interest than it pays, so coverage of interest payments is not a concern.